Healthcare provider profile · identity verified

Fadi Salloum, MD

Allopathic & Osteopathic Physicians|Internal Medicine · PONTIAC, MI · NPI 1205874831

Profile state: payments and partd Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

CMS Open Payments records show Fadi Salloum, MD received $124.08 in general payments during 2025 across 1 reported records.

AstraZeneca Pharmaceuticals LP accounted for 100.0% of that reported general-payment amount.

AstraZeneca Pharmaceuticals LP reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported BRILINTA as an associated drug or biological on 993 records involving 512 distinct recipient NPIs. Public Medicare Part D data also shows 69 claims for Brilinta by this doctor in 2024.

AstraZeneca Pharmaceuticals LP reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported FARXIGA as an associated drug or biological on 106133 records involving 42906 distinct recipient NPIs. Public Medicare Part D data also shows 100 claims for Farxiga by this doctor in 2024.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

$124.08

1 reported records · 1 companies

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Who paid this doctor?

Companies in 2025 General Payments

Reported company	Canonical company	Amount	Share	Records	Year
AstraZeneca Pharmaceuticals LP	Unresolved — no canonical attribution shown	$124.08	100.0%	1	2025

What were the payments for?

Payment categories

Category	Amount	Records
Food and Beverage	$124.08	1

A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.

Analysis 1 · Payment-linked products

Products named in Open Payments records

Payment records were found, but the reported records did not identify a specific associated product for this analysis.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

Paying company	Payment year	Drug reported by same entity	Open Payments evidence	Part D	Claims	Beneficiaries
AstraZeneca Pharmaceuticals LP Exact reporting entity; no affiliate inference	2025	BRILINTA open payments reported associated product	CMS Open Payments — General Payments 993 supporting records · 512 recipient NPIs · example record 1206131430	Brilinta · 2024 Exact normalized brand match · 1 Part D row	69	suppressed by CMS
AstraZeneca Pharmaceuticals LP Exact reporting entity; no affiliate inference	2025	FARXIGA open payments reported associated product	CMS Open Payments — General Payments 106133 supporting records · 42906 recipient NPIs · example record 1206131362	Farxiga · 2024 Exact normalized brand match · 1 Part D row	100	16

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	1851	304
Eliquis	Apixaban	1275	130
Levothyroxine Sodium	Levothyroxine Sodium	1023	155
Furosemide	Furosemide	852	168
Amlodipine Besylate	Amlodipine Besylate	773	129
Metoprolol Tartrate	Metoprolol Tartrate	673	122
Tamsulosin Hcl	Tamsulosin Hcl	653	102
Metoprolol Succinate	Metoprolol Succinate	647	113
Losartan Potassium	Losartan Potassium	599	104
Clopidogrel	Clopidogrel Bisulfate	484	86
Donepezil Hcl	Donepezil Hcl	446	65
Lisinopril	Lisinopril	435	91
Mirtazapine	Mirtazapine	381	82
Potassium Chloride	Potassium Chloride	381	71
Sertraline Hcl	Sertraline Hcl	381	64
Gabapentin	Gabapentin	379	90
Metformin Hcl	Metformin Hcl	379	62
Omeprazole	Omeprazole	346	83
Trazodone Hcl	Trazodone Hcl	332	70
Memantine Hcl	Memantine Hcl	331	58
Pantoprazole Sodium	Pantoprazole Sodium	320	69
Quetiapine Fumarate	Quetiapine Fumarate	318	66
Levetiracetam	Levetiracetam	288	41
Carvedilol	Carvedilol	282	61
Duloxetine Hcl	Duloxetine Hcl	256	45
Hydralazine Hcl	Hydralazine Hcl	251	46
Famotidine	Famotidine	249	50
Escitalopram Oxalate	Escitalopram Oxalate	244	40
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	236	44
Finasteride	Finasteride	227	33
Warfarin Sodium	Warfarin Sodium	202	16
Divalproex Sodium	Divalproex Sodium	198	34
Januvia	Sitagliptin Phosphate	197	20
Montelukast Sodium	Montelukast Sodium	193	33
Humalog Kwikpen U-100	Insulin Lispro	192	38
Latanoprost	Latanoprost	182	38
Spironolactone	Spironolactone	178	26
Simvastatin	Simvastatin	163	25
Baclofen	Baclofen	157	28
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	152	41
Jardiance	Empagliflozin	152	23
Bumetanide	Bumetanide	151	35
Fluticasone Propionate	Fluticasone Propionate	150	48
Xarelto	Rivaroxaban	142	15
Isosorbide Mononitrate Er	Isosorbide Mononitrate	139	30
Entresto	Sacubitril/Valsartan	132	20
Oxybutynin Chloride Er	Oxybutynin Chloride	130	25
Myrbetriq	Mirabegron	129	13
Buspirone Hcl	Buspirone Hcl	124	26
Citalopram Hbr	Citalopram Hydrobromide	123	18
Midodrine Hcl	Midodrine Hcl	120	33
Risperidone	Risperidone	114	30
Carbidopa-Levodopa	Carbidopa/Levodopa	113	20
Novolog Flexpen	Insulin Aspart	110	22
Hydrochlorothiazide	Hydrochlorothiazide	105	20
Lamotrigine	Lamotrigine	105	19
Methocarbamol	Methocarbamol	104	25
Bupropion Xl	Bupropion Hcl	102	16
Meloxicam	Meloxicam	102	20
Albuterol Sulfate Hfa	Albuterol Sulfate	100	50
Farxiga	Dapagliflozin Propanediol	100	16
Olanzapine	Olanzapine	100	14
Rosuvastatin Calcium	Rosuvastatin Calcium	100	17
Timolol Maleate	Timolol Maleate	96	16
Allopurinol	Allopurinol	95	18
Arexvy	Rsvpref3 Antigen/As01e/Pf	95	94
Nifedipine Er	Nifedipine	95	21
Pravastatin Sodium	Pravastatin Sodium	94	14
Budesonide	Budesonide	92	16
Ondansetron Hcl	Ondansetron Hcl	92	52
Brimonidine Tartrate	Brimonidine Tartrate	91	14
Enulose	Lactulose	91	14
Ropinirole Hcl	Ropinirole Hcl	90	13
Prednisone	Prednisone	89	40
Ezetimibe	Ezetimibe	88	14
Aripiprazole	Aripiprazole	86	23
Paroxetine Hcl	Paroxetine Hcl	84	15
Amiodarone Hcl	Amiodarone Hcl	81	19
Fluoxetine Hcl	Fluoxetine Hcl	79	19
Nystop	Nystatin	79	43
Methenamine Hippurate	Methenamine Hippurate	78	15
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	77	39
Atenolol	Atenolol	76	11
Sucralfate	Sucralfate	74	18
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	69	16
Brilinta	Ticagrelor	69	suppressed
Novolog	Insulin Aspart	68	14
Albuterol Sulfate	Albuterol Sulfate	67	34
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	67	15
Lantus	Insulin Glargine,hum.Rec.Anlog	63	15
Linzess	Linaclotide	63	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	63	43
Nystatin	Nystatin	62	36
Sodium Chloride	0.9 % Sodium Chloride	62	15
Triamcinolone Acetonide	Triamcinolone Acetonide	62	19
Alendronate Sodium	Alendronate Sodium	61	14
Ciprofloxacin Hcl	Ciprofloxacin Hcl	59	37
Levofloxacin	Levofloxacin	59	38
Primidone	Primidone	59	suppressed
Cephalexin	Cephalexin	57	37
Santyl	Collagenase Clostridium Hist.	57	21
Gemtesa	Vibegron	56	suppressed
Incruse Ellipta	Umeclidinium Bromide	56	suppressed
Folic Acid	Folic Acid	55	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	55	12
Clobetasol Propionate	Clobetasol Propionate	54	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	52	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	51	28
Lactulose	Lactulose	50	11
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	48	18
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	47	12
Fenofibrate	Fenofibrate	47	suppressed
Fluconazole	Fluconazole	47	34
Vitamin D2	Ergocalciferol (Vitamin D2)	45	suppressed
Colchicine	Colchicine	43	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	43	12
Carbamazepine	Carbamazepine	42	suppressed
Benztropine Mesylate	Benztropine Mesylate	41	suppressed
Fiasp Flextouch	Insulin Aspart (Niacinamide)	41	suppressed
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	41	13
Mesalamine	Mesalamine	41	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	41	11
Doxazosin Mesylate	Doxazosin Mesylate	40	suppressed
Levemir Flexpen	Insulin Detemir	39	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	39	25
Breo Ellipta	Fluticasone/Vilanterol	38	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	38	25
Pregabalin	Pregabalin	38	suppressed
Cefpodoxime Proxetil	Cefpodoxime Proxetil	37	21
Clonidine Hcl	Clonidine Hcl	37	suppressed
Tradjenta	Linagliptin	36	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	36	suppressed
Admelog Solostar	Insulin Lispro	35	suppressed
Ibuprofen	Ibuprofen	35	17
Labetalol Hcl	Labetalol Hcl	35	suppressed
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	33	suppressed
Digoxin	Digoxin	33	suppressed
Dorzolamide-Timolol	Dorzolamide Hcl/Timolol Maleat	32	suppressed
Topiramate	Topiramate	32	suppressed
Glipizide	Glipizide	31	suppressed
Hydrocortisone	Hydrocortisone	31	13
Lorazepam	Lorazepam	31	16
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	30	suppressed
Rexulti	Brexpiprazole	30	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	29	12
Isosorbide Dinitrate	Isosorbide Dinitrate	29	suppressed
Ranolazine Er	Ranolazine	29	suppressed
Xifaxan	Rifaximin	29	suppressed
Ammonium Lactate	Ammonium Lactate	28	21
Desmopressin Acetate	Desmopressin Acetate	28	suppressed
Insulin Aspart Flexpen	Insulin Aspart	28	suppressed
Lansoprazole	Lansoprazole	28	suppressed
Diclofenac Sodium	Diclofenac Sodium	27	14
Trulicity	Dulaglutide	27	suppressed
Creon	Lipase/Protease/Amylase	26	suppressed
Trospium Chloride	Trospium Chloride	26	suppressed
Valsartan	Valsartan	26	suppressed
Cilostazol	Cilostazol	25	suppressed
Oxcarbazepine	Oxcarbazepine	25	suppressed
Propranolol Hcl	Propranolol Hcl	25	suppressed
Travoprost	Travoprost	25	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	24	suppressed
Breyna	Budesonide/Formoterol Fumarate	24	suppressed
Dapagliflozin	Dapagliflozin Propanediol	24	15
Ketoconazole	Ketoconazole	24	15
Savaysa	Edoxaban Tosylate	24	suppressed
Benazepril Hcl	Benazepril Hcl	23	suppressed
Prednisolone Acetate	Prednisolone Acetate	23	suppressed
Valproic Acid	Valproic Acid (As Sodium Salt)	23	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	22	suppressed
Calcitonin-Salmon	Calcitonin,salmon,synthetic	22	suppressed
Calcium Acetate	Calcium Acetate	22	suppressed
Lithium Carbonate	Lithium Carbonate	22	suppressed
Megestrol Acetate	Megestrol Acetate	22	suppressed
Metformin Hcl Er	Metformin Hcl	22	suppressed
Nitroglycerin	Nitroglycerin	22	18
Ondansetron Odt	Ondansetron	22	11
Quetiapine Fumarate Er	Quetiapine Fumarate	22	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	21	19
Anastrozole	Anastrozole	20	suppressed
Methimazole	Methimazole	20	suppressed
Novofine Autocover	Pen Needle, Diabetic, Safety	20	suppressed
Nyamyc	Nystatin	20	13
Rivastigmine	Rivastigmine	20	suppressed
Bupropion Hcl	Bupropion Hcl	19	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	19	suppressed
Divalproex Sodium Er	Divalproex Sodium	19	suppressed
Eraxis	Anidulafungin	19	suppressed
Letrozole	Letrozole	19	suppressed
Metolazone	Metolazone	19	suppressed
Single Use Swab	Alcohol Antiseptic Pads	19	suppressed
Bupropion Hcl Sr	Bupropion Hcl	18	suppressed
Cholestyramine	Cholestyramine (With Sugar)	18	suppressed
Doxepin Hcl	Doxepin Hcl	18	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	18	suppressed
Nitrofurantoin	Nitrofurantoin Macrocrystal	18	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	18	18
Pioglitazone Hcl	Pioglitazone Hcl	18	suppressed
Rivastigmine	Rivastigmine Tartrate	18	suppressed
Scopolamine	Scopolamine	18	suppressed
Tizanidine Hcl	Tizanidine Hcl	18	suppressed
Alphagan P	Brimonidine Tartrate	17	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	17	suppressed
Dimethyl Fumarate	Dimethyl Fumarate	17	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	17	12
Nystatin-Triamcinolone	Nystatin/Triamcinolone Acet	17	suppressed
Semglee (Yfgn)	Insulin Glargine-Yfgn	17	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	17	suppressed
Azithromycin	Azithromycin	16	11
Glimepiride	Glimepiride	16	suppressed
Lovastatin	Lovastatin	16	suppressed
Meclizine Hcl	Meclizine Hcl	16	suppressed
Mupirocin	Mupirocin	16	suppressed
Nuedexta	Dextromethorphan Hbr/Quinidine	16	suppressed
Paliperidone Er	Paliperidone	16	suppressed
Perphenazine	Perphenazine	16	suppressed
Zenpep	Lipase/Protease/Amylase	16	suppressed
Alprazolam	Alprazolam	15	suppressed
Clindamycin Hcl	Clindamycin Hcl	15	11
Fenofibrate	Fenofibrate Nanocrystallized	15	suppressed
Fludrocortisone Acetate	Fludrocortisone Acetate	15	suppressed
Formoterol Fumarate	Formoterol Fumarate	15	suppressed
Heparin Sodium	Heparin Sodium,porcine	15	suppressed
Pentoxifylline	Pentoxifylline	15	suppressed
Propafenone Hcl	Propafenone Hcl	15	suppressed
Spiriva Respimat	Tiotropium Bromide	15	suppressed
Stiolto Respimat	Tiotropium Br/Olodaterol Hcl	15	suppressed
Cefepime Hcl	Cefepime Hcl	14	suppressed
Ceftriaxone	Ceftriaxone Sodium	14	suppressed
Flecainide Acetate	Flecainide Acetate	14	suppressed
Fluticasone-Vilanterol	Fluticasone/Vilanterol	14	suppressed
Humalog Mix 75-25	Insulin Lispro Protamin/Lispro	14	suppressed
Irbesartan	Irbesartan	14	suppressed
Tramadol Hcl	Tramadol Hcl	14	suppressed
Trintellix	Vortioxetine Hydrobromide	14	suppressed
Zonisamide	Zonisamide	14	suppressed
Diltiazem 12hr Er	Diltiazem Hcl	13	suppressed
Erythromycin	Erythromycin Base	13	suppressed
Humalog	Insulin Lispro	13	suppressed
Ipratropium Bromide	Ipratropium Bromide	13	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	13	suppressed
Oxycodone Hcl	Oxycodone Hcl	13	suppressed
Torsemide	Torsemide	13	suppressed
Tresiba Flextouch U-100	Insulin Degludec	13	suppressed
Ventolin Hfa	Albuterol Sulfate	13	11
Amoxicillin	Amoxicillin	12	suppressed
Carbidopa-Levodopa Er	Carbidopa/Levodopa	12	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	12	suppressed
Fluphenazine Hcl	Fluphenazine Hcl	12	suppressed
Imatinib Mesylate	Imatinib Mesylate	12	suppressed
Ofloxacin	Ofloxacin	12	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	12	suppressed
Pyridostigmine Bromide	Pyridostigmine Bromide	12	suppressed
Spiriva Handihaler	Tiotropium Bromide	12	suppressed
Chlorhexidine Gluconate	Chlorhexidine Gluconate	11	suppressed
Cyclosporine	Cyclosporine	11	suppressed
Enoxaparin Sodium	Enoxaparin Sodium	11	suppressed
Fiasp	Insulin Aspart (Niacinamide)	11	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	11	suppressed
Lamotrigine Odt	Lamotrigine	11	suppressed
Lumigan	Bimatoprost	11	suppressed
Valacyclovir	Valacyclovir Hcl	11	suppressed
Verapamil Hcl	Verapamil Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	$124.08 · 1 records	AstraZeneca Pharmaceuticals LP	—	2	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

How do you evaluate evidence when you have a financial relationship with AstraZeneca Pharmaceuticals LP?
Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error